Medicine
Sumatriptan 6 mg/0.5 mL injection
Sumatriptan 6 mg/0.5 mL injection is a generic prescription medicine for subcutaneous use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted 15°C to 30°C (59°F to 86°F)…
Key facts
- Active ingredient (INN)
- Sumatriptan
- Brand
- Sold under the generic name
- Strength
- 6 mg/0.5 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 2 syringes of 0.5 mL, 1 syringe of 0.5 mL, 5 vials of 0.5 mL and 30 more
- Manufacturers
- Alembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaEugiaIndiaStrides PharmaIndiaSun Pharmaceutical IndustriesIndiaCaplin SterilesIndiaOnesource Specialty PharmaBaxter HealthcareA-S Medication SolutionsHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted 15°C to 30°C (59°F to 86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02CC01 Sumatriptan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 June 2010
- Identifiers
- RxCUI 1657151, 313165, 727339 +1DailyMed set ID 8fef1176-7a38-eca3-22ca-83efe5ca6620, 9b1bb8c9-be3a-47c3-b3bc-9c983cde7d23, 38fd19bf-b7aa-812c-8a74-2414dfec45f4 +21NDC 43598-768, 55150-173, 72603-141 +21Application ANDA090495, ANDA202758, ANDA090314 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 syringe in 1 carton / .5 mL in 1 syringe | 46708-657-01 | Alembic PharmaceuticalsIndia | 6 November 2025 |
| 1 syringe in 1 carton / .5 mL in 1 syringe | 46708-657-05 | Alembic PharmaceuticalsIndia | 6 November 2025 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 62332-657-01 | Alembic PharmaceuticalsIndia | 6 November 2025 |
| 1 syringe in 1 carton / .5 mL in 1 syringe | 62332-657-05 | Alembic PharmaceuticalsIndia | 6 November 2025 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 43598-768-23 | Dr. Reddy's LaboratoriesIndia | 20 April 2023 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 55111-693-12 | Dr. Reddy's LaboratoriesIndia | 24 February 2014 |
| 5 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 55150-173-01 | EugiaIndia | 23 April 2013 |
| 5 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 55150-173-05 | EugiaIndia | 23 April 2013 |
| 5 vial in 1 carton / .5 mL in 1 vial | 65145-118-05 | Caplin SterilesIndia | 28 September 2024 |
| 1 syringe in 1 carton / .5 mL in 1 syringe | 64380-740-01 | Strides PharmaIndia | 16 March 2026 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 64380-740-02 | Strides PharmaIndia | 16 March 2026 |
| 1 syringe in 1 package / .5 mL in 1 syringe | 47335-276-40 | Sun Pharmaceutical IndustriesIndia | 20 August 2025 |
| 2 syringe in 1 package / .5 mL in 1 syringe | 47335-276-41 | Sun Pharmaceutical IndustriesIndia | 20 August 2025 |
| 1 blister pack in 1 carton / 1 syringe in 1 blister pack / .5 mL in 1 syringe | 83270-005-01 | Onesource Specialty Pharma | 30 June 2025 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 83270-151-07 | Onesource Specialty Pharma | 2 February 2026 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 83270-152-07 | Onesource Specialty Pharma | 2 February 2026 |
| 5 vial in 1 carton / .5 mL in 1 vial | 83270-156-06 | Onesource Specialty Pharma | 9 July 2023 |
| 5 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 72485-518-05 | Armas Pharmaceuticals | 1 June 2026 |
| 5 vial in 1 carton / .5 mL in 1 vial | 36000-289-05 | Baxter Healthcare | 19 January 2023 |
| 10 vial in 1 carton / .5 mL in 1 vial | 36000-289-10 | Baxter Healthcare | 19 January 2023 |
| 25 vial in 1 carton / .5 mL in 1 vial | 36000-289-25 | Baxter Healthcare | 19 January 2023 |
| 1 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 63323-273-01 | Fresenius Kabi | 12 April 2011 |
| 5 vial in 1 carton / .5 mL in 1 vial | 0143-9638-05 | Hikma Pharmaceuticals | 16 September 2013 |
| 25 vial in 1 carton / .5 mL in 1 vial | 0143-9638-25 | Hikma Pharmaceuticals | 16 September 2013 |
| 1 vial in 1 carton / .5 mL in 1 vial | 70069-804-01 | Somerset Therapeutics | 25 October 2021 |
| 5 vial in 1 carton / .5 mL in 1 vial | 70069-804-05 | Somerset Therapeutics | 25 October 2021 |
| 5 vial in 1 carton / .5 mL in 1 vial | 70594-068-02 | Xellia Pharmaceuticals | 1 January 2022 |
| 5 vial in 1 carton / .5 mL in 1 vial | 50090-2497-0 | A-S Medication Solutions | 13 October 2016 |
| 5 vial in 1 carton / .5 mL in 1 vial | 50090-7957-0 | A-S Medication Solutions | 4 May 2026 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 85766-238-02 | Sportpharm | 9 July 2026 |
| 5 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 85766-259-05 | Sportpharm | 23 July 2026 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 51407-673-02 | Golden State Medical Supply | 20 February 2026 |
| 2 syringe in 1 carton / .5 mL in 1 syringe | 72603-141-02 | NorthStar Rx | 13 June 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 December 1992 | Drugs@FDA |
| EU (EMA) | Refused | EMA medicines data |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sumatriptan 6 mg/0.5 mL injection.
Other strengths and forms of Sumatriptan
Clinical summary
Sumatriptan is a serotonin-1b and serotonin-1d receptor agonist indicated in adults for the acute treatment of migraine, with or without aura, and the acute treatment of cluster headache, among other approved uses. MedsAcross supplies Sumatriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SumatriptanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- IMITREX prescribing information (GlaxoSmithKline) · U.S. National Library of Medicine, DailyMed
Need Sumatriptan 6 mg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.